| Literature DB >> 34857050 |
Nórton Luís Oliveira1,2, Cíntia Ehlers Botton3,4, Angélica Trevisan De Nardi4,5, Daniel Umpierre3,4,5,6.
Abstract
BACKGROUND: Several resources have been developed (e.g., reporting guidelines) to promote high-standard practices in health research. However, there was no continuous and systematic assessment of recommended practices in published systematic reviews with meta-analysis (SRMAs), which increases the usability of the available resources. Therefore, we aimed to assess the methodological and reporting standards in SRMAs of physical activity studies. This report presents the main results of the SEES Initiative in 2019.Entities:
Keywords: Exercise sciences; Methodological quality; Reporting standards; Systematic reviews with meta-analysis
Mesh:
Year: 2021 PMID: 34857050 PMCID: PMC8638189 DOI: 10.1186/s13643-021-01845-9
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Fig. 1Flow diagram of the study selection process. SRMAs, systematic reviews with meta-analysis
Fig. 2Overview of the adherence to recommended practices: items (n = 36) per SRMA (n = 103). Rows refer to items/recommended practices (n = 36) and columns refer to systematic reviews with meta-analysis (n = 103). The studies are organized in descending order of adherence to the items/recommended practices (from left to right). Four items of transparency: 1T: Registration; 2T: Protocol; 3T: Available searches; 4T: Data Statement. Eleven items of completeness: 1C: Title as SRMA; 2C: Data sources (abstract); 3C: Key eligibility criteria (abstract); 4C: Number of included studies (abstract); 5C: Research question; 6C: PICOS explanation; 7C: Number of references; 8C: Description of sample sizes; 9C: Duration of included studies; 10C: Sources of funding; 11C: Potential conflicts of interest. Two items of participants: 1P: Description of participants (abstract); 2P: Detailed studies' characteristics. Two items of interventions/exposures: 1I: Description of interventions/exposures (ab); 2I: Detailed studies' characteristics. Five items of outcome: 1O: Main outcome of interest (abstract); 2O: Statistical methods; 3O: Statistical heterogeneity; 4O: Meta-analytic summary estimates; 5O: Statistics per study. Seven items of methodological rigor 1M: Searches in grey literature; 2M: Searches from inception or with justification; 3M: Number of languages; 4M: Study selection in duplicate; 5M: Data extraction in duplicate; 6M: Description of Risk of Bias assessment; 7M: Risk of Bias assessment in duplicate. Five items of critical appraisal: 1Cr: Risk of Bias results within studies; 2Cr: Description of protocol deviations; 3Cr: Presence of spin bias; 4Cr: Discussion addressing Risk of Bias; 5Cr: Limitations thoroughly addressed. The list with the identification of the studies in this same order is available in the Additional file 7
Frequency distribution of items/recommended practices by domains for the total number of systematic reviews with meta-analysis (SRMAs)
| SRMAs ( | |
|---|---|
| | |
| No | 46 (44.7%) |
| Yes | 57 (55.3%) |
| | |
| No | 98 (95.1%) |
| Yes | 5 (4.9%) |
| | |
| No | 20 (19.4%) |
| Yes | 83 (80.6%) |
| | |
| No | 66 (64.1%) |
| Yes | 37 (35.9%) |
| | |
| No | 3 (2.9%) |
| Yes | 100 (97.1%) |
| | |
| No | 33 (32.0%) |
| Yes | 70 (68.0%) |
| | |
| No | 26 (25.2%) |
| Yes | 77 (74.8%) |
| | |
| No | 5 (4.9%) |
| Yes | 98 (95.1%) |
| | |
| No | 29 (28.2%) |
| Yes | 74 (71.8%) |
| | |
| No | 32 (31.1%) |
| Yes | 71 (68.9%) |
| | |
| No | 6 (5.8%) |
| Yes | 97 (94.2%) |
| | |
| No | 5 (4.9%) |
| Yes | 98 (95.1%) |
| | |
| Does not apply | 16 (15.5%) |
| No | 7 (6.8%) |
| Yes | 80 (77.7%) |
| | |
| No | 7 (6.8%) |
| Yes | 96 (93.2%) |
| | |
| No | 7 (6.8%) |
| Yes | 96 (93.2%) |
| | |
| No | 22 (21.4%) |
| Yes | 81 (78.6%) |
| | |
| No | 15 (14.6%) |
| Yes | 88 (85.4%) |
| | |
| No | 7 (6.8%) |
| Yes | 96 (93.2%) |
| | |
| No | 15 (14.6%) |
| Yes | 88 (85.4%) |
| | |
| No | 5 (4.9%) |
| Yes | 98 (95.1%) |
| | |
| No | 18 (17.5%) |
| Yes | 85 (82.5%) |
| | |
| No | 12 (11.7%) |
| Yes | 91 (88.3%) |
| | |
| No | 31 (30.1%) |
| Yes | 72 (69.9%) |
| | |
| No | 46 (44.7%) |
| Yes | 57 (55.3%) |
| | |
| No | 49 (47.6%) |
| Yes | 54 (52.4%) |
| | |
| No | 8 (7.8%) |
| Yes | 95 (92.2%) |
| | |
| 1 | 62 (60.2%) |
| 2 | 11 (10.7%) |
| 3 | 7 (6.8%) |
| 4 | 1 (1.0%) |
| No restriction | 19 (18.4%) |
| No statement | 3 (2.9%) |
| | |
| No | 26 (25.2%) |
| Partial yes (e.g., a sample of 50% of studies were checked by two independent researchers) | 3 (2.9%) |
| Yes | 74 (71.8%) |
| | |
| No | 47 (45.6%) |
| Partial yes (e.g., a sample of 50% of studies were checked by two independent researchers) | 1 (1.0%) |
| Yes | 55 (53.4%) |
| | |
| No | 5 (4.9%) |
| Yes | 98 (95.1%) |
| | |
| No | 35 (34.0%) |
| Yes | 68 (66.0%) |
| | |
| No | 14 (13.6%) |
| Partial yes (there are individual results without specification of specific criteria/domains) | 17 (16.5%) |
| Yes | 72 (69.9%) |
| | |
| No | 18 (17.5%) |
| Unclear | 43 (41.7%) |
| Yes | 16 (15.5%) |
| Does not apply | 26 (25.2%) |
| | |
| No | 82 (79.6%) |
| Yes | 21 (20.4%) |
| | |
| No | 70 (68.0%) |
| Yes | 33 (32.0%) |
| | |
| No | 6 (5.8%) |
| Yes, BOTH for study and review levels | 74 (71.9%) |
| Yes, ONLY for the review level (limitation within or across studies not mentioned) | 2 (1.9%) |
| Yes, ONLY for the study and/or outcome level (review processes not mentioned) | 21 (20.4%) |
ab Abstract, PICOS Acronym for population, intervention, comparator/control, outcome, setting, RoB Risk of bias